588
Views & Citations10
Likes & Shares
Disease Management is an intellectual exercise which needs inputs from
Social, Economics, Logistics, Clinical expertise, psychology. Medicine plays an
important role as they are to be purchased or reimbursed. If the medicines are
expensive, where patients have not been covered by Insurance and are purchasing
in out of pocket. The poor accessibility, affordability and patient compliance
are the outcome due to medicine s. Especially in Chronic conditions, when
patients are buying medicines out of pocket when they are having meager income.
In this article, we discussed how the medicines impact the disease management.
INTRODUCTION
Medicines play a vital role in patient compliance and adherence to treatment especially in developing and non-develop economize. The price of the medicine is the cause of concern for various stack holders apart from patient and health consumers [1]. The regulation of the s has become vital even in develop the economics like USA, Canada and Australia each country have their own rules and regulation to have a control over some of medicine. Looking their advancement in technologies the affordable medicines should not be impossible task however geopolitical conditions and pharmaceutical industries make the situation worst leading to high of medicines for patients along with stake holder like insurance providers, government and other intermediate stake older comparing the medicines are similar in lines of consumers goods like foods items as simply complicated the issues the major differences between the food items and medicine. Markets work well in the interest of the society when there is price competition, comprehensive, accurate, unbiased medicine information and on adequate supply of drugs, where consumers are able to make informed unpressured choices between competing products and when there are few barriers for entry to the market [2]. Food items are not regulatory astringent lost because food items form safe and consume to anybody of any amount. Medicines are to be used under the recommendation of prescribers and may pose serious health issues if and health used in irrational manner it is to understand every medicine has its own protocol for storage, uses and comes with date of expiry, these conditions make medicine special products to be stored and dispense to the patients and health consumers against the prescription by the registered medical practitioners. The pharmacist is being designated as the custodians of medicines, in this back draw the role of pharmaceuticals industries, pharmaceutical sales professional, distributers, doctors, pharmacist, patient and health consumers form the basic supply chain. The medicines being sensitive to environmental factors need to be preserved under suitable conditions which also add to be cost of the medicines [3]. The complex nature of pricing of medicines as lead to blurring of the showoff pricing the medicine manufactures claimed that they are not charging heavily the patient and heath consumers and it is always a balancing act foreign industries between profit and loss they also enjoyed trust and goodwill of the public and other stack holders that their services to humanity is very noble like that of doctors and many a time their mistake are simply ignored and over looked [4]. In reality, pharmaceutical industries have an immersed profitable industries and evergreen industries. The medicine price discrimination plays role in increment of medicine prices, for example the price discrimination by health practitioners by scaling fees to the income of patients [5]. The pharma industry is in famous for following double standard and is showing a false image to the public but practicing unethical marketing leading to corruption of in the field of medicine. This differs from most other countries, where drug prices are regulated either directly through price control (e.g. France and Italy) or indirectly through limits on reimbursement under social insurance schemes (e.g. Germany and Japan) or indirectly through profit controls, e.g. United Kingdom [6]. Careful selection of a limited range of essential medicines results in a good quality of care, better management of medicines and more cost-effective use of health resources [7]. Medicine Prices Availability and Affordability measures patient affordability by estimating the number of daily wages – using the salary of the lowest-paid unskilled government worker – required to purchase a course of treatment. Such measurements provide a precise snapshot of a medicine’s affordability in any given context, helping to quantify the impoverishing effect of purchasing medicines [8,9].
In India health insurance ease in preliminary stage the patient and the
health consumers are purchasing medicines by out of the pocket expenses
although the government of India has made an initiative like Jan Aushadhi
Kendra where the medicine and related disease management and diagnostic are
made available at 50% s compare to branded medicines are available in the open
market. However, the effort of government of India closed to be very marginal
in the total market very few people are able to make use of Jan Aushadhi
Medicine. Government of India has also brought several rules and regulations to
check the s of the medicines throughout post independent era. The first of its
kinds ease drug price control order of India and several amendments further
government of India also form the body called as drug price control orders and
BPPI [10].
CONCLUSION
It is very much evident that pricing of medicines involves various
steps and considerations which need to be included in the finals of medicines
for examples the medicines should have consideration of pricing of active
pharmaceutical ingredients, pharmaceutical cost industrial overhead marketing
cost which include margin on sells for C&F agents, distributers and retail
sells. If the API is under patent should also include the royalty expenses for
the patent holders. In over all the entrepreneurs who take the responsibility
of manufacturing and providing medicines should and up with sustainable profit
for this the government have made a suitable framework and given enough space
of operation for pharmaceutical. Despite of the provision the industries is
behaving in a greedy manner leading to escalating the medicine s it is also
mandatory to have control and check over the industries by monitoring their
ethical marketing practices and identifying the wrong practices prosecuting the
offenders which can ensures the pricing the control of medicine in a
sustainable manner.
1.
(2007) Essential drugs
for hospitals under government of NCT of Delhi. EML for Hospitals.
2.
Bigdeli M, Peters DH,
Wagner AK (2014) Medicines in health systems: Advancing access, affordability
and appropriate use. World Health Organization.
3.
Cameron A, Ewen M,
Ross-Degnan D, Ball D, Laing R (2009) Medicines, availability and affordability
in 36 developing and middle-income countries: A secondary analysis. Lancet 373:
240-249.
4.
Jain NK (2015) Pharmaceutical
jurisprudence. Vallabh Prakashan, 4th revised (Edn.). Drug Control,
pp: 107-122.
5.
(1995) Drugs (Control)
Order.
6.
http://www.indianmedicine.nic.in/writereaddata/mainlinkFile/File222.pdf
7.
The M/o Health and
Family Welfare and Ministry of AYUSH also govern various aspects relating to
pharmaceutical companies.
8.
http://nrhm.gov.in/images/pdf/in-focus/Shimla/Guidelines/Free_Drugs_Service_Intitiative.pdf
9.
(2018) Bureau of Pharma
PSUs of India (BPPI) (Under Department of Pharmaceuticals, Govt of India).
10.
http://nrhm.gov.in/images/pdf/in-focus/Shimla/Guidelines/Free_Drugs_Service_Intitiative.pdf
QUICK LINKS
- SUBMIT MANUSCRIPT
- RECOMMEND THE JOURNAL
-
SUBSCRIBE FOR ALERTS
RELATED JOURNALS
- Journal of Forensic Research and Criminal Investigation (ISSN: 2640-0846)
- Journal of Renal Transplantation Science (ISSN:2640-0847)
- International Journal of Clinical Case Studies and Reports (ISSN:2641-5771)
- Stem Cell Research and Therapeutics (ISSN:2474-4646)
- Journal of Clinical Trials and Research (ISSN:2637-7373)
- International Journal of Anaesthesia and Research (ISSN:2641-399X)
- Journal of Immunology Research and Therapy (ISSN:2472-727X)